These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 30358224)
41. Bioinformatics analysis of molecular mechanisms of chronic obstructive pulmonary disease. Chen W; Hong YQ; Meng ZL Eur Rev Med Pharmacol Sci; 2014; 18(23):3557-63. PubMed ID: 25535123 [TBL] [Abstract][Full Text] [Related]
42. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus. Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912 [TBL] [Abstract][Full Text] [Related]
43. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
44. Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling. Hu F; Li H; Liu L; Xu F; Lai S; Luo X; Hu J; Yang X Mol Cancer; 2018 Jul; 17(1):107. PubMed ID: 30060750 [TBL] [Abstract][Full Text] [Related]
46. Proteogenomics for the Study of Gastrointestinal Stromal Tumors. Kondo T Adv Exp Med Biol; 2016; 926():139-151. PubMed ID: 27686810 [TBL] [Abstract][Full Text] [Related]
47. miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors. Huang WK; Akçakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Åhlén J; Bränström R; Larsson C; Lui WO Exp Cell Res; 2018 Oct; 371(1):287-296. PubMed ID: 30149002 [TBL] [Abstract][Full Text] [Related]
48. Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene. Indio V; Astolfi A; Tarantino G; Urbini M; Patterson J; Nannini M; Saponara M; Gatto L; Santini D; do Valle IF; Castellani G; Remondini D; Fiorentino M; von Mehren M; Brandi G; Biasco G; Heinrich MC; Pantaleo MA Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510530 [TBL] [Abstract][Full Text] [Related]
49. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis. Hu S; Liao Y; Chen L Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925 [TBL] [Abstract][Full Text] [Related]
50. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis. Liang B; Li C; Zhao J Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154 [TBL] [Abstract][Full Text] [Related]
51. ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors. Jang BG; Lee HE; Kim WH Virchows Arch; 2015 Oct; 467(4):393-403. PubMed ID: 26243012 [TBL] [Abstract][Full Text] [Related]
52. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study. Murphy JD; Ma GL; Baumgartner JM; Madlensky L; Burgoyne AM; Tang CM; Martinez ME; Sicklick JK Cancer; 2015 Sep; 121(17):2960-7. PubMed ID: 25930983 [TBL] [Abstract][Full Text] [Related]
53. Immune Infiltration, Cancer Stemness, and Targeted Therapy in Gastrointestinal Stromal Tumor. Wang J; Ren H; Wu W; Zeng Q; Chen J; Han J; Lin M; Zhang C; He Y; Li M Front Immunol; 2021; 12():691713. PubMed ID: 34925310 [TBL] [Abstract][Full Text] [Related]
54. Promoting role of cholecystokinin 2 receptor (CCK2R) in gastrointestinal stromal tumour pathogenesis. Quattrone A; Dewaele B; Wozniak A; Bauters M; Vanspauwen V; Floris G; Schöffski P; Chibon F; Coindre JM; Sciot R; Debiec-Rychter M J Pathol; 2012 Dec; 228(4):565-74. PubMed ID: 22786615 [TBL] [Abstract][Full Text] [Related]
55. Everything you always wanted to know about GIST (but were afraid to ask) An update on GIST pathology. Ricci R; Saragoni L Pathologica; 2016 Sep; 108(3):90-103. PubMed ID: 28195260 [TBL] [Abstract][Full Text] [Related]
56. SLITRK3 expression correlation to gastrointestinal stromal tumor risk rating and prognosis. Wang CJ; Zhang ZZ; Xu J; Wang M; Zhao WY; Tu L; Zhuang C; Liu Q; Shen YY; Cao H; Zhang ZG World J Gastroenterol; 2015 Jul; 21(27):8398-407. PubMed ID: 26217092 [TBL] [Abstract][Full Text] [Related]
57. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer. Ye Y; Li SL; Wang SY PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363 [TBL] [Abstract][Full Text] [Related]
58. Identification of candidate target genes of pituitary adenomas based on the DNA microarray. Zhou W; Ma CX; Xing YZ; Yan ZY Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791 [TBL] [Abstract][Full Text] [Related]
59. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
60. Transcriptional Regulatory Network Analysis for Gastric Cancer Based on mRNA Microarray. Wang Y Pathol Oncol Res; 2017 Oct; 23(4):785-791. PubMed ID: 28078605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]